David Haselbach joins EMBO Young Investigator programme
David Haselbach, Technology Platform Head for cryo electron microscopy, was selected by the European Molecular Biology Organization (EMBO) to take part in its prestigious Young Investigator Programme. EMBO will support Haselbach’s research for the next four years through its international network of more than 700 life scientists. Alejandro Burga from the neighbouring institute IMBA has also been appointed to the programme.
Every year, the European Molecular Biology Organization (EMBO) selects the most promising group leaders in Europe to take part in its Young Investigator Programme. Candidates must have established their labs within the four years preceding their application and go through a highly competitive selection to join the programme. For this year, 26 researchers have been selected as new EMBO Young Investigators; among them is IMP Technology Platform Head David Haselbach.
David Haselbach is a structural biologist using mainly cryo-electron microscopy in his work. He joined the IMP initially as a fellow in 2017 and was promoted to group leader three years later. Since October, he is the head of the cryo-EM Technology Platform.
EMBO Young Investigators are within their first four years of being principal investigators and have a proven record of scientific excellence. As part of the Young Investigator Programme, they have access to a wide range of benefits including networking opportunities, training in leadership skills and responsible research practices, and access to core facilities at the European Molecular Biology Laboratory (EMBL). Young Investigators receive an award of 15,000 Euro in the second year of their tenure, and can apply for further funding, travel grants, and take advantage of mentorship opportunities.
Alejandro Burga from the neighbouring Institute of Molecular Biotechnology (IMBA) has also been appointed to the programme.
The European Molecular Biology Organization (EMBO) is an international organisation for life sciences and directs funding from member states towards research fellowships, courses, workshops, conferences, and science policy initiatives. EMBO also publishes a range of life science journals. The administrative headquarters is in Heidelberg, Germany. www.embo.org.
About David Haselbach
David Haselbach joined the IMP as fellow in 2017 and was promoted to Group Leader in 2020. Very recently, he assumed a new role of Technology Platform Head. Employing innovative biophysical methods, particularly cryo-electron microscopy, Haselbach observes molecular machines in operation to unravel their underlying principles in structure and function.
Before joining the IMP, Haselbach was a postdoc at the Max Planck Institute for Biophysical Chemistry in Göttingen, where he also completed his PhD. Earlier in his academic journey, he studied single molecule biophysics during his master's thesis at the Technical University of Munich. His initial foray into the Max Planck Society occurred through research for his bachelor's thesis at the Max Planck Institute for Molecular Genetics in Berlin.